home / stock / revb / revb quote
Last: | $22.52 |
---|---|
Change Percent: | -3.64% |
Open: | $22.41 |
Close: | $22.52 |
High: | $23.06 |
Low: | $21 |
Volume: | 1,500 |
Last Trade Date Time: | 03/31/2020 04:46:33 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.52 | $22.41 | $22.52 | $23.06 | $21 | 1,500 | 03-31-2020 |
$23.34 | $23 | $23.34 | $23.35 | $21.01 | 3,415 | 03-30-2020 |
$23.57 | $23.51 | $23.57 | $23.58 | $23.51 | 941 | 03-27-2020 |
$22.57 | $23 | $22.57 | $24.63 | $22.12 | 6,441 | 03-26-2020 |
$23 | $23.25 | $23 | $23.5 | $21.5001 | 27,700 | 03-25-2020 |
$23.0525 | $21.45 | $23.0525 | $23.71 | $21.02 | 52,116 | 03-24-2020 |
$20.63 | $20.6175 | $20.63 | $20.63 | $19.5675 | 330,250 | 03-23-2020 |
$21.73 | $19.4875 | $21.73 | $21.73 | $19.4875 | 25,403 | 03-19-2020 |
$ | $37.30 | $37.30 | $37.30 | $37.30 | 515 | 02-12-2020 |
$ | $37.23 | $37.15 | $37.42 | $37.15 | 14,501 | 02-11-2020 |
$ | $36.72 | $36.57 | $36.72 | $36.57 | 2,800 | 02-10-2020 |
$ | $37.00 | $36.85 | $37.00 | $36.85 | 427 | 02-07-2020 |
$ | $37.50 | $37.47 | $37.50 | $37.20 | 33,515 | 02-06-2020 |
$ | $36.95 | $37.60 | $37.60 | $36.60 | 21,888 | 02-05-2020 |
$ | $36.60 | $36.60 | $37.00 | $36.60 | 12,125 | 02-04-2020 |
$ | $36.10 | $36.48 | $36.50 | $35.75 | 18,904 | 02-03-2020 |
$ | $36.43 | $36.15 | $36.43 | $35.65 | 5,246 | 01-31-2020 |
$ | $36.1501 | $36.45 | $36.45 | $36.00 | 5,411 | 01-30-2020 |
$ | $36.75 | $36.36 | $36.75 | $36.0601 | 23,866 | 01-29-2020 |
$ | $36.90 | $36.70 | $36.95 | $36.55 | 7,354 | 01-28-2020 |
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
OTCMKTS Market:
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...
– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or ...
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rol...